Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary

R L Incorvati1, S G Tauberg, M J Pecora

  • 1Department of Medicine, Allegheny General Hospital, Medical College of Pennsylvania, Pittsburgh.

Insights

Synchronized coronary sinus retroperfusion of arterial blood effectively reduced myocardial ischemia during high-risk coronary angioplasty. This technique improved wall motion abnormalities without increasing ST segment deviation, supporting its use in cardiac interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Physiology

Background:

  • Coronary sinus retroperfusion (CSR) has shown promise in supporting ischemic heart muscle.
  • Previous studies in animals and humans indicate CSR's efficacy in myocardial protection.

Purpose of the Study:

  • To evaluate the effectiveness of synchronized coronary sinus retroperfusion of arterial blood.
  • To determine if CSR reduces myocardial ischemia during high-risk coronary angioplasty.

Main Methods:

  • Twenty-one patients undergoing high-risk coronary angioplasty were randomized.
  • CSR support was provided during angioplasty balloon inflations.
  • Myocardial ischemia was assessed using echocardiography, ST segment deviation, and hemodynamic variables.

Main Results:

  • CSR significantly reduced left anterior descending wall motion abnormalities (p < 0.05).
  • No additional ST segment deviation was observed despite longer supported inflations (p < 0.004).
  • Coronary sinus pressures were significantly higher during CSR (p < 0.001).

Conclusions:

  • CSR effectively reduces myocardial ischemia, evidenced by improved wall motion during angioplasty.
  • CSR does not exacerbate ischemic changes on ECG, even with prolonged support.
  • The technique offers a promising adjunct for high-risk coronary angioplasty procedures.
Abstract